Mary Jane Verastigue is a Clinical Quality and Training Manager at Novo Nordisk Pharmaceuticals Pty Ltd, based in Sydney, with over 20 years of experience in clinical research, quality assurance, and training. In her current role, she leads clinical quality oversight and inspection readiness across the Oceania Clinical Development Centre, embedding quality‑by‑design principles across the trial lifecycle to ensure sustained GCP compliance and regulatory defensibility. She provides strategic oversight of audits, inspections, and GCP activities, translating regulatory expectations into practical, system‑based controls that reduce reliance on late‑stage remediation. Mary Jane also designs and delivers targeted, compliance‑focused training programs that strengthen role clarity, accountability, and evidence generation, while leveraging audit and operational data to drive continuous improvement and a proactive quality culture within clinical operations.
